Overview
Tsubasa Okano practices in Tokyo, Japan. Mr. Okano is rated as an Experienced expert by MediFind in the treatment of X-Linked Lymphoproliferative Disease. His top areas of expertise are Primary Immunodeficiency (PID), X-Linked Severe Combined Immunodeficiency, Severe Combined Immunodeficiency (SCID), ZAP70-Related Severe Combined Immunodeficiency, and Bone Marrow Transplant.
His clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of X-Linked Lymphoproliferative Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Primary Immunodeficiency (PID)Mr. Okano isAdvanced. Learn about Primary Immunodeficiency (PID).
- Severe Combined Immunodeficiency (SCID)
- X-Linked Severe Combined Immunodeficiency
- ZAP70-Related Severe Combined Immunodeficiency
- Experienced
- Activated PI3K Delta Syndrome (APDS)Mr. Okano isExperienced. Learn about Activated PI3K Delta Syndrome (APDS).
- Ataxia-TelangiectasiaMr. Okano isExperienced. Learn about Ataxia-Telangiectasia.
- Bone Marrow TransplantMr. Okano isExperienced. Learn about Bone Marrow Transplant.
- Burkitt LymphomaMr. Okano isExperienced. Learn about Burkitt Lymphoma.
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Granulomatous DiseaseMr. Okano isExperienced. Learn about Chronic Granulomatous Disease.